Sign inGet started

Renzi David

Insider CIK 1631294 · CBYL President & CEO, Director · UTRS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
UTRS MINERVA SURGICAL INC A Award2022-06-102022-06-1449,792$2.41 $120.0K49,792SEC↗
CBYL KalVista Pharmaceuticals, M Exercise deriv2016-11-212016-11-2336,640— $00SEC↗
CBYL KalVista Pharmaceuticals, F Tax w/h2016-11-212016-11-2333,454$8.59 $287.4K3,186SEC↗
CBYL KalVista Pharmaceuticals, U Tender2016-11-212016-11-233,186$8.59 $27.4K0SEC↗
CBYL KalVista Pharmaceuticals, M Exercise2016-11-212016-11-2336,640$7.84 $287.3K36,640SEC↗
CBYL Carbylan Therapeutics, Inc A Award deriv2016-01-042016-01-05283,000— $0283,000SEC↗
CBYL Carbylan Therapeutics, Inc M Exercise deriv2015-12-302015-12-3110,000— $0515,825SEC↗
CBYL Carbylan Therapeutics, Inc M Exercise2015-12-302015-12-3110,000$0.56 $5.6K10,000SEC↗
CBYL Carbylan Therapeutics, Inc S Sale2015-12-302015-12-3110,000$3.70 $37.0K0SEC↗
CBYL Carbylan Therapeutics, Inc A Award deriv2015-08-032015-08-05276,506— $0276,506SEC↗